Clinical Trial Update: A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of PF-06647020 in adults with advanced solid tumors completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• PF-06647020

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2020-12-17